Eyad Elkord
Eyad Elkord
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα salford.ac.uk
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
DS Vinay, EP Ryan, G Pawelec, WH Talib, J Stagg, E Elkord, T Lichtor, ...
Seminars in cancer biology 35, S185-S198, 2015
6752015
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
A Jaggupilli, E Elkord
Clinical and Developmental Immunology 2012, 2012
4292012
Immune checkpoint inhibitors: recent progress and potential biomarkers
P Darvin, SM Toor, VS Nair, E Elkord
Experimental & molecular medicine 50 (12), 1-11, 2018
3872018
Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting
B Chaudhary, E Elkord
Vaccines 4 (3), 28, 2016
2762016
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S Daayana, E Elkord, U Winters, M Pawlita, R Roden, PL Stern, ...
British journal of cancer 102 (7), 1129-1136, 2010
2252010
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma
C Ralph, E Elkord, DJ Burt, JF O'Dwyer, EB Austin, PL Stern, RE Hawkins, ...
Clinical Cancer Research 16 (5), 1662-1672, 2010
2242010
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
RW Griffiths, E Elkord, DE Gilham, V Ramani, N Clarke, PL Stern, ...
Cancer Immunology, Immunotherapy 56 (11), 1743-1753, 2007
2052007
Myeloid‐derived suppressor cells in cancer: recent progress and prospects
YS Khaled, BJ Ammori, E Elkord
Immunology and cell biology 91 (8), 493-502, 2013
1912013
Designing a broad-spectrum integrative approach for cancer prevention and treatment
KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ...
Seminars in cancer biology 35, S276-S304, 2015
1902015
Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells
E Elkord, PE Williams, H Kynaston, AW Rowbottom
Immunology 114 (2), 204-212, 2005
1812005
Neuropilin 1: function and therapeutic potential in cancer
B Chaudhary, YS Khaled, BJ Ammori, E Elkord
Cancer Immunology, Immunotherapy 63 (2), 81-99, 2014
1472014
T regulatory cells in cancer: recent advances and therapeutic potential
E Elkord, EM Alcantar-Orozco, SJ Dovedi, DQ Tran, RE Hawkins, ...
Expert opinion on biological therapy 10 (11), 1573-1586, 2010
1172010
Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients
YS Khaled, BJ Ammori, E Elkord
Journal of Immunology Research 2014, 9, 2014
1042014
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia
U Winters, S Daayana, JT Lear, AE Tomlinson, E Elkord, PL Stern, ...
Clinical Cancer Research 14 (16), 5292-5299, 2008
932008
Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
V Sasidharan Nair, E Elkord
Immunology & Cell Biology 96 (1), 21-33, 2018
902018
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
E Elkord, M Abd Al Samid, B Chaudhary
Oncotarget 6 (24), 20026-20036, 2015
712015
Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs
E Elkord, S Sharma, DJ Burt, RE Hawkins
Clinical immunology 140 (3), 218-222, 2011
642011
Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
S Khan, DJ Burt, C Ralph, FC Thistlethwaite, RE Hawkins, E Elkord
Clinical Immunology 138 (1), 85-96, 2011
572011
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
ASS Khaja, SM Toor, H El Salhat, I Faour, NU Haq, BR Ali, E Elkord
Oncotarget 8 (20), 33159, 2017
542017
Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation
E Elkord
Journal of immunological methods 347 (1-2), 87-90, 2009
522009
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20